South Sudan vs Yemen: Population requiring preventive chemotherapy for schistosomiasis
South Sudan
3.75 million
in 2024
Yemen
3.85 million
in 2024
South Sudan rank
22nd
Yemen rank
21st
Population requiring preventive chemotherapy for schistosomiasis over time
- South Sudan
- Yemen
How they compare
Yemen currently reports 3.85 million against 3.75 million in South Sudan, a difference of 97,830.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was Yemen ahead.
South Sudan ranks 22nd and Yemen ranks 21st of 52 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.57 million | 4.99 million | 2.42 million | Yemen |
| 2020s | 3.48 million | 3.75 million | 275,026 | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, South Sudan or Yemen?
- Yemen, at 3.85 million against 3.75 million in South Sudan as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between South Sudan and Yemen?
- 97,830, with Yemen ahead.
- How many years of comparable data are there for South Sudan and Yemen?
- 12 years are reported by both, from 2013 to 2024.
- How do South Sudan and Yemen rank globally for population requiring preventive chemotherapy for schistosomiasis?
- South Sudan ranks 22nd and Yemen ranks 21st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.